NAFDAC cautions against use of Covifor Remidesivir Injection, says product is suspicious
The warning is contained in a statement signed by the agency’s Director General, Prof. Mojisola Adeyeye, on Friday in Abuja.
She said that the label on the vaccine indicates that it was “Not for distribution in US, Canada or EU”, thus creating suspicion about its efficacy and could also have negative effect on the body system.
“The product is suspicious, and it could possibly be a falsified product, the general public is hereby warned to desist from the use of such product,” Adeyeye stressed. (NAN)